500 related articles for article (PubMed ID: 28586243)
1. Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.
Winters-Stone KM; Horak F; Jacobs PG; Trubowitz P; Dieckmann NF; Stoyles S; Faithfull S
J Clin Oncol; 2017 Aug; 35(23):2604-2612. PubMed ID: 28586243
[TBL] [Abstract][Full Text] [Related]
2. Identifying trajectories and predictors of chemotherapy-induced peripheral neuropathy symptoms, physical functioning, and falls across treatment and recovery in adults treated with neurotoxic chemotherapy: the PATTERN observational study protocol (NCT05790538).
Winters-Stone KM; Krasnow SM; Horak FB; Mancini M; Cameron MH; Dieckmann NF; Stoyles SA; Roeland EJ
BMC Cancer; 2023 Nov; 23(1):1087. PubMed ID: 37946117
[TBL] [Abstract][Full Text] [Related]
3. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-Induced Peripheral Neuropathy and Falls in Cancer Survivors Relate to Digital Balance and Gait Impairments.
Shah VV; Muzyka D; Guidarelli C; Sowalsky K; Horak FB; Winters-Stone KM
JCO Precis Oncol; 2024 Jun; 8():e2300312. PubMed ID: 38885463
[TBL] [Abstract][Full Text] [Related]
5. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.
Bao T; Basal C; Seluzicki C; Li SQ; Seidman AD; Mao JJ
Breast Cancer Res Treat; 2016 Sep; 159(2):327-33. PubMed ID: 27510185
[TBL] [Abstract][Full Text] [Related]
6. Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial.
Teran-Wodzinski P; Haladay D; Vu T; Ji M; Coury J; Adams A; Schwab L; Visovsky C
Trials; 2022 Apr; 23(1):363. PubMed ID: 35477489
[TBL] [Abstract][Full Text] [Related]
7. Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test.
McCrary JM; Goldstein D; Wyld D; Henderson R; Lewis CR; Park SB
J Cancer Surviv; 2019 Aug; 13(4):495-502. PubMed ID: 31172429
[TBL] [Abstract][Full Text] [Related]
8. Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer Treatments.
McCrary JM; Goldstein D; Trinh T; Timmins HC; Li T; Menant J; Friedlander M; Lewis CR; Hertzberg M; O'Neill S; King T; Bosco A; Harrison M; Park SB
J Natl Compr Canc Netw; 2019 Aug; 17(8):949-955. PubMed ID: 31390588
[TBL] [Abstract][Full Text] [Related]
9. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Roles of Central and Peripheral Nervous System Function in Gait Stability: Preliminary Insights from Cancer Survivors.
Monfort SM; Pan X; Loprinzi CL; Lustberg MB; Chaudhari AMW
Gait Posture; 2019 Jun; 71():62-68. PubMed ID: 31009918
[TBL] [Abstract][Full Text] [Related]
11. Interactive Sensor-Based Balance Training in Older Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial.
Schwenk M; Grewal GS; Holloway D; Muchna A; Garland L; Najafi B
Gerontology; 2016; 62(5):553-63. PubMed ID: 26678611
[TBL] [Abstract][Full Text] [Related]
12. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
Wong ML; Cooper BA; Paul SM; Abrams G; Topp K; Kober KM; Chesney MA; Mazor M; Schumacher MA; Conley YP; Levine JD; Miaskowski C
Support Care Cancer; 2019 Oct; 27(10):3905-3912. PubMed ID: 30770977
[TBL] [Abstract][Full Text] [Related]
13. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
Knoerl R; Weller E; Halpenny B; Berry D
BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
[TBL] [Abstract][Full Text] [Related]
14. Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN.
Zahiri M; Chen KM; Zhou H; Nguyen H; Workeneh BT; Yellapragada SV; Sada YH; Schwenk M; Najafi B
J Geriatr Oncol; 2019 Nov; 10(6):960-967. PubMed ID: 30665876
[TBL] [Abstract][Full Text] [Related]
15. Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors.
Galantino ML; Tiger R; Brooks J; Jang S; Wilson K
Integr Cancer Ther; 2019; 18():1534735419850627. PubMed ID: 31131640
[TBL] [Abstract][Full Text] [Related]
16. Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy.
Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB
Gait Posture; 2021 Sep; 89():178-185. PubMed ID: 34320441
[TBL] [Abstract][Full Text] [Related]
17. The detrimental association between fear of falling and motor performance in older cancer patients with chemotherapy-induced peripheral neuropathy.
Kang GE; Murphy TK; Kunik ME; Badr HJ; Workeneh BT; Yellapragada SV; Sada YH; Najafi B
Gait Posture; 2021 Jul; 88():161-166. PubMed ID: 34091147
[TBL] [Abstract][Full Text] [Related]
18. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study.
Gewandter JS; Fan L; Magnuson A; Mustian K; Peppone L; Heckler C; Hopkins J; Tejani M; Morrow GR; Mohile SG
Support Care Cancer; 2013 Jul; 21(7):2059-66. PubMed ID: 23446880
[TBL] [Abstract][Full Text] [Related]
19. Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).
Binda D; Vanhoutte EK; Cavaletti G; Cornblath DR; Postma TJ; Frigeni B; Alberti P; Bruna J; Velasco R; Argyriou AA; Kalofonos HP; Psimaras D; Ricard D; Pace A; Galiè E; Briani C; Dalla Torre C; Lalisang RI; Boogerd W; Brandsma D; Koeppen S; Hense J; Storey D; Kerrigan S; Schenone A; Fabbri S; Rossi E; Valsecchi MG; Faber CG; Merkies IS; ; Galimberti S; Lanzani F; Mattavelli L; Piatti ML; Bidoli P; Cazzaniga M; Cortinovis D; Lucchetta M; Campagnolo M; Bakkers M; Brouwer B; Boogerd W; Grant R; Reni L; Piras B; Pessino A; Padua L; Granata G; Leandri M; Ghignotti I; Plasmati R; Pastorelli F; Heimans JJ; Eurelings M; Meijer RJ; Grisold W; Lindeck Pozza E; Mazzeo A; Toscano A; Russo M; Tomasello C; Altavilla G; Penas Prado M; Dominguez Gonzalez C; Dorsey SG
Eur J Cancer; 2013 Sep; 49(13):2910-8. PubMed ID: 23668917
[TBL] [Abstract][Full Text] [Related]
20. Living with chemotherapy-induced peripheral neuropathy: Uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors.
Chan CW; Cheng H; Au SK; Leung KT; Li YC; Wong KH; Molassiotis A
Eur J Oncol Nurs; 2018 Oct; 36():135-141. PubMed ID: 30322504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
